Live Breaking News & Updates on Associate Professors Aaron Sverdlov

Stay updated with breaking news from Associate professors aaron sverdlov. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Race Oncology Ltd extends collaborative research program with University of Newcastle for cardio-protective drug Zantrene® in cancer patients

This strategically important collaboration will underpin a cardio-protective Phase 2b clinical trial in cancer patients at high risk of. ....

Daniel Tillett , Aaron Sverdlov , Doan Ngo , Race Oncology Ltd , National Heart Foundation Future Leader Fellowship , Hunter Medical Research Institute , Hunter New England Local Health District , University Of Newcastle , Associate Professors Aaron Sverdlov , Calvary Mater Newcastle , Rising Stars ,

Race Oncology Ltd interim results for Zantrene oncology treatment "remarkable", protects heart from cell death during chemotherapy

“Zantrene is the first anti-cancer agent that we have found to exhibit a cardioprotective profile while being synergistically effective as an. ....

Daniel Tillett , Aaron Sverdlov , Doan Ngo , Nikki Verrills , Phillip Lynch , Race Oncology Ltd , University Of Newcastle , Associate Professors Aaron Sverdlov , Associate Professor Nikki Verrills , Race Oncology , Acute Myeloid Leukaemia , Three Pillar ,

Race Oncology Ltd interim results for Zantrene oncology treatment "remarkable", protects heart from cell death during chemotherapy

“Zantrene is the first anti-cancer agent that we have found to exhibit a cardioprotective profile while being synergistically effective as an. ....

Daniel Tillett , Aaron Sverdlov , Doan Ngo , Nikki Verrills , Phillip Lynch , Race Oncology Ltd , University Of Newcastle , Associate Professors Aaron Sverdlov , Associate Professor Nikki Verrills , Race Oncology , Acute Myeloid Leukaemia , Three Pillar ,

Race Oncology Ltd targets multiple cancer indications as it advances Zantrene

Clinical stage RNA focused company targeting multiple cancer indications with estimated annual oncology revenues of >US$2.6 billion ....

United States , Daniel Tillett , Chaim Sheba , Aaron Sverdlov , Doan Ngo , Xu Dong Zhang , Nikki Verrills , Phillip Lynch , Race Oncology Ltd , University Of Newcastle , Acute Myeloid Leukaemia , Australian Phase , Three Pillar , Professor Nagler , Chaim Sheba Israel , Professor Xu Dong Zhang , Associate Professor Lei Jin , Associate Professors Aaron Sverdlov , Associate Professor Nikki Verrills ,

Breakthrough Chemotherapy Heart Protection Discovery for Australian Biotech

Race Oncology’s drug Zantrene shown to protect human heart muscle cells from anthracycline-induced chemotherapy death. Anthracycline’s are the most used. ....

New South Wales , Daniel Tillett , Aaron Sverdlov , Doan Ngo , Nikki Verrills , University Of Newcastle , Race Oncology , Associate Professors Aaron Sverdlov , Associate Professor Nikki Verrills , Professor Aaron Sverdlov , Chief Scientific Officer ,